BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22115541)

  • 1. Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis.
    Olaleye O; Raghunand TR; Bhat S; Chong C; Gu P; Zhou J; Zhang Y; Bishai WR; Liu JO
    Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1(Suppl 1):S61-5. PubMed ID: 22115541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets.
    Olaleye O; Raghunand TR; Bhat S; He J; Tyagi S; Lamichhane G; Gu P; Zhou J; Zhang Y; Grosset J; Bishai WR; Liu JO
    Chem Biol; 2010 Jan; 17(1):86-97. PubMed ID: 20142044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis.
    John SF; Aniemeke E; Ha NP; Chong CR; Gu P; Zhou J; Zhang Y; Graviss EA; Liu JO; Olaleye OA
    Tuberculosis (Edinb); 2016 Dec; 101S():S73-S77. PubMed ID: 27856197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase.
    Onyenaka C; Idowu KA; Ha NP; Graviss EA; Olaleye OA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogs of N'-hydroxy-N-(4H,5H-naphtho[1,2-d]thiazol-2-yl)methanimidamide inhibit Mycobacterium tuberculosis methionine aminopeptidases.
    Bhat S; Olaleye O; Meyer KJ; Shi W; Zhang Y; Liu JO
    Bioorg Med Chem; 2012 Jul; 20(14):4507-13. PubMed ID: 22704656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Mycobacterium tuberculosis methionine aminopeptidases by bengamide derivatives.
    Lu JP; Yuan XH; Yuan H; Wang WL; Wan B; Franzblau SG; Ye QZ
    ChemMedChem; 2011 Jun; 6(6):1041-8. PubMed ID: 21465667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal extension present in the methionine aminopeptidase type 1c of Mycobacterium tuberculosis is indispensible for its activity.
    Kanudia P; Mittal M; Kumaran S; Chakraborti PK
    BMC Biochem; 2011 Jul; 12():35. PubMed ID: 21729287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of Mycobacterium tuberculosis methionine aminopeptidase type 1a.
    Lu JP; Ye QZ
    Bioorg Med Chem Lett; 2010 May; 20(9):2776-9. PubMed ID: 20363127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis.
    Olaleye OA; Bishai WR; Liu JO
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S55-9. PubMed ID: 20006307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of inhibition of Mycobacterium tuberculosis methionine aminopeptidase by bengamide derivatives.
    Lu JP; Yuan XH; Ye QZ
    Eur J Med Chem; 2012 Jan; 47(1):479-84. PubMed ID: 22118830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and characterization of two functional methionine aminopeptidases from Mycobacterium tuberculosis H37Rv.
    Zhang X; Chen S; Hu Z; Zhang L; Wang H
    Curr Microbiol; 2009 Nov; 59(5):520-5. PubMed ID: 19688379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalysis and inhibition of Mycobacterium tuberculosis methionine aminopeptidase.
    Lu JP; Chai SC; Ye QZ
    J Med Chem; 2010 Feb; 53(3):1329-37. PubMed ID: 20038112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases.
    Ekpenyong O; Gao X; Ma J; Cooper C; Nguyen L; Olaleye OA; Liang D; Xie H
    Drug Des Devel Ther; 2020; 14():1263-1277. PubMed ID: 32280198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1.
    Juhás M; Pallabothula VSK; Grabrijan K; Šimovičová M; Janďourek O; Konečná K; Bárta P; Paterová P; Gobec S; Sosič I; Zitko J
    Bioorg Chem; 2022 Jan; 118():105489. PubMed ID: 34826708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
    Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO
    Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple, sensitive and reliable LC-MS/MS method for the determination of 7-bromo-5-chloroquinolin-8-ol (CLBQ14), a potent and selective inhibitor of methionine aminopeptidases: Application to pharmacokinetic studies.
    Ekpenyong O; Cooper C; Ma J; Liang D; Olaleye O; Xie H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():35-43. PubMed ID: 30199748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Potential Antituberculosis Agents Targeted Methionine Aminopeptidase 1 of
    Zhang M; He S; Han X; Cui J; Wang H; Huo X; Yan F; Feng L; Wang C; Ma X
    Anal Chem; 2023 Nov; 95(44):16210-16215. PubMed ID: 37899593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl hydroxamic acids as methionine aminopeptidase inhibitors.
    Hu X; Zhu J; Srivathsan S; Pei D
    Bioorg Med Chem Lett; 2004 Jan; 14(1):77-9. PubMed ID: 14684302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.